WBCPI 100.32 0.0% CBA 164.72 0.5801% BHP 38.06 0.9014% RIO 114.92 0.9576% CSL 241.89 0.8884% WBC 32.04 1.0726% NAB 35.11 0.6017% NEM 85.2 3.4608% WES 75.74 -0.0396% ANZ 28.84 1.5493% MQG 192.72 1.2291% GMG 28.74 0.8421% XYZ 88.34 -0.2484% RMD 36.08 8.5113% TLS 4.44 -0.4484% FMG 15.52 1.0417% TCL 13.89 0.072% ALL 64.25 0.0779% WOW 31.53 -0.3791% WDS 20.01 -2.0078%

Global Commodity Technical Analysis Report

Bullish momentum in the Commodity Market Last Week, One Commodity Below Resistance Level – NATURAL GAS

Feb 24, 2025

NG
Investment Type
Commodity
Risk Level
Action
Rec. Price (US$)

 Global Commodity Market Wrap-Up

The metals market showed strong performance last week, with precious metals maintaining their upward momentum, while base metals also joined the rally, gaining alongside precious metals last week. Gold surged by 1.79%, reaching a new high, and silver climbed by 0.48%. Base metals followed suit, with copper rising by 1.03%, lead increasing by 1.28%, and zinc jumping by 3.00%. These movements highlight shifting investor sentiment and varying demand across sectors. After a period of stability, the market has entered a more volatile phase, suggesting that price movements will be influenced by these changing dynamics. The overall outlook remains uncertain.

Last week, natural gas prices jumped by 11.29%, fueled by supply constraints and rising seasonal demand. In contrast, crude oil prices fell by 0.44%, as market uncertainty and shifting investor sentiment weighed on the commodity. U.S. sugar prices rose by 3.97%, standing out amid mostly declining agricultural commodities. These movements highlight the ongoing impact of supply-demand imbalances, with investors adjusting strategies in response to global economic uncertainties. The energy markets are experiencing heightened volatility, while the agricultural market remains range-bound, influenced by supply disruptions and changing demand trends, suggesting continued price fluctuations.

Xxxxxx Xxxxxx Xxxxxx

Xxxxxx Xxxxxx

Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .

Xxxxxx Xxxxxx Xxxxxx Xxxxxx & Xxxxxx

  • Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx
  • Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .

Xxxxxx Xxxxxx

Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .

Xxxxxx

Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .   


Disclaimer-

Disclaimer This report has been issued by Kalkine New Zealand Limited (FSP691351) (NZBN:9429047678101) (“Kalkine”). Kalkine is a Financial Advice Provider (“FAP”) and is authorised by a Class 1 Financial Advice Provider Licence issued by Financial Markets Authority (“FMA”) to provide financial advice. Kalkine provides only general financial advice through its research reports following a person becoming a member. The reports contain buy/sell/hold and other recommendations in relation to equity securities, managed funds and other managed investment schemes and other financial advice products. The recommendations and opinions in this report and on Kalkine website do not take into account any of your investment objectives, financial situation or needs. Before you make a decision about whether to acquire a financial product, you should obtain the Product Disclosure Statement from the product issuer. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. If you act on the advice in the research reports, you may have to pay fees, expenses or other amounts (but not to Kalkine). Further information about the complaints and dispute resolution process, as well as information about Kalkine’s duties are available on Kalkine’s website. Please read our Financial Advice Provider (FAP) disclosure statement and Complaints Handling Guide, which are available on the website.